Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.

Cancer Biol Ther · 2022 · PMC8966983 · PMID 35343367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

AURKB, CDC6, CCNB1, and FOXM1 showed differential decreases in resistant cell lines at both the 24-hours and 72-hour time points but failed to reach significance in the sensitive cell lines.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.